Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 14, 2013 | CEO | 15,000 | $70.17 | Sell | $1,052,550.00 | |
| May 13, 2013 | SVP | 1,248 | $69.26 | Sell | $86,436.48 | |
| May 13, 2013 | CEO | 15,800 | $68.77 | Sell | $1,086,566.00 | |
| May 8, 2013 | CEO | 4,000 | $65.87 | Sell | $263,480.00 | |
| May 2, 2013 | CEO | 3,000 | $64.99 | Sell | $194,970.00 | |
| April 10, 2013 | EVP | 20,000 | $64.00 | Sell | $1,280,000.00 | |
| March 22, 2013 | VP | 3,103 | $60.21 | Sell | $186,831.63 | |
| March 4, 2013 | SVP | 4,000 | $60.18 | Sell | $240,720.00 | |
| Feb. 22, 2013 | VP | 3,103 | $55.22 | Sell | $171,347.66 | |
| Feb. 4, 2013 | CEO | 2,000 | $55.77 | Sell | $111,540.00 | |
| Dec. 27, 2012 | CEO | 17,000 | $48.37 | Sell | $822,290.00 | |
| Nov. 12, 2012 | SVP | 99,075 | $48.45 | Sell | $4,800,183.75 | |
| Sept. 4, 2012 | EVP | 5,000 | $37.76 | Sell | $188,800.00 | |
| Aug. 22, 2012 | VP | 2,665 | $37.93 | Sell | $101,083.45 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.